In the latest report released by the German publication Der Spiegel as part of their Football Leaks series,Real Madrid captain, Sergio Ramos failed a drugs test in the aftermath of his team’s 2017 Champions League final.
It is alleged that Ramos tested positive for dexamethasone, a glucocorticoid drug that is only permitted if a medical doctor reports its administration.
Der Spiegel reports that Ramos’ urine sample contained traces of dexamethasone, and that the results were covered up by UEFA.
However, the German magazine also reports that UEFA were satisfied the mistake was an administrative error and took no disciplinary action.
Der Spiegel have made a further allegation that Sergio Ramos ignored instructions from an anti-doping officer to give a sample before showering. Obstructing the doping control process is an offence that can be punished by up to a four-year ban.
The cortisone preparation is on the list kept by the World Anti-Doping Agency (WADA) of substances that are prohibited in competition.
After Uefa investigated the incident and asked the club and player for expectations, it was the doctor who would take the blame – claiming “human error”.
Real Madrid said Ramos “has never breached anti-doping regulations”, while Uefa says it “strongly and categorically refutes unfounded allegations” that the governing body had covered up doping. Madrid denied any breach, saying in a statement: Sergio Ramos has never breached the anti-doping control regulations.
Also UEFA requested timely information and closed the matter immediately, as is usual in these cases, after verification by the experts themselves of the World Anti-Doping Agency, AMA, and of UEFA itself.
Regarding the rest of the content of the aforementioned publication, the club does not pronounce itself before the evidence of its insubstantial nature.”
The Football Leaks revelations also claim that Ramos’ former team-mate Ronaldo ‘complained that he was always selected’ for testing when UEFA arrived at the club’s training ground for random testing in February 2017.